EP1406659A1 - Agents pharmaceutiques contenant de l'acyclovir, de l'acide fusarique et des derives de cet acide - Google Patents

Agents pharmaceutiques contenant de l'acyclovir, de l'acide fusarique et des derives de cet acide

Info

Publication number
EP1406659A1
EP1406659A1 EP01957154A EP01957154A EP1406659A1 EP 1406659 A1 EP1406659 A1 EP 1406659A1 EP 01957154 A EP01957154 A EP 01957154A EP 01957154 A EP01957154 A EP 01957154A EP 1406659 A1 EP1406659 A1 EP 1406659A1
Authority
EP
European Patent Office
Prior art keywords
agent
composition
preparation
group
range
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP01957154A
Other languages
German (de)
English (en)
Inventor
Avinash N. Amin
Michael G. Douglas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novactyl Inc
Original Assignee
Novactyl Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novactyl Inc filed Critical Novactyl Inc
Publication of EP1406659A1 publication Critical patent/EP1406659A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Abstract

L'invention concerne des compositions comprenant au moins un inhibiteur, analogue de nucléoside, des sels, des solvates ou des promédicaments de cet inhibiteur, acceptables sur le plan pharmaceutique, et de l'acide fusarique, des dérivés ou des sels de cet acide, acceptables sur le plan pharmaceutique. Les compositions pharmaceutiques comprenant ces compositions peuvent aussi contenir un autre composé thérapeutiquement efficace, notamment comme support. L'invention concerne aussi des préparations générales ou locales comprenant ces compositions, ainsi que des méthodes de traitement de maladies virales consistant à administrer ces agents antiviraux à un sujet.
EP01957154A 2001-07-11 2001-07-11 Agents pharmaceutiques contenant de l'acyclovir, de l'acide fusarique et des derives de cet acide Withdrawn EP1406659A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2001/022228 WO2003006062A1 (fr) 2001-07-11 2001-07-11 Agents pharmaceutiques contenant de l'acyclovir, de l'acide fusarique et des derives de cet acide

Publications (1)

Publication Number Publication Date
EP1406659A1 true EP1406659A1 (fr) 2004-04-14

Family

ID=21742700

Family Applications (1)

Application Number Title Priority Date Filing Date
EP01957154A Withdrawn EP1406659A1 (fr) 2001-07-11 2001-07-11 Agents pharmaceutiques contenant de l'acyclovir, de l'acide fusarique et des derives de cet acide

Country Status (2)

Country Link
EP (1) EP1406659A1 (fr)
WO (1) WO2003006062A1 (fr)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6127393A (en) * 1995-12-29 2000-10-03 Novactyl, Inc. Antiproliferative, antiinfective, antiinflammatory, autologous immunization agent and method

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO03006062A1 *

Also Published As

Publication number Publication date
WO2003006062A1 (fr) 2003-01-23

Similar Documents

Publication Publication Date Title
US10137140B2 (en) Therapeutic composition
AU701574B2 (en) Acyclovir derivatives for topical use
US5756116A (en) Nucleoside phosphate therapy for viral infection
US20200054552A1 (en) Medicament for the treatment of viral skin and tumour diseases
RU2251415C2 (ru) Синергетическое ингибирование вирусной репликации длинноцепочечными углеводородами и нуклеозидными аналогами
US6569864B1 (en) Pharmaceutical agents containing acyclovir, fusaric acid and derivatives thereof
JP2724711B2 (ja) 医薬品生成物
CA1092510A (fr) No translation available
US20180133239A1 (en) Therapeutic composition
WO2003006062A1 (fr) Agents pharmaceutiques contenant de l'acyclovir, de l'acide fusarique et des derives de cet acide
RU2071323C1 (ru) Противовирусный препарат "полирем"
CA2173505C (fr) Utilisation de la penciclovir dans le traitement de nevralgie post-herpetique
US8044098B2 (en) Use of hydroxybenzoic acids and their esters and analogues for preventing or treating virus infection
Smith et al. Experimental Ocular Herpetic Infections in Rabbits: Treatment With 9-([2-Hydroxy-1-(hydroxymethyl) ethoxy] methyl) guanine
Shannon et al. Evaluation of prodrugs of 9-beta-D-arabinofuranosyladenine for therapeutic efficacy in the topical treatment of genital herpesvirus infections in guinea pigs
CA1302887C (fr) Melange d'acyclovir (ou d'un de ses devises) et de bacitracine
US6015573A (en) Nucleoside phosphate therapy for viral infection
WO2019136196A1 (fr) Composition thérapeutique
JP2002540150A (ja) ウイルス治療
US5955446A (en) Method of treating herpes infections with 2',5'-oligoadenylate-2',3'-cyclophosphate compounds
WO2017062421A1 (fr) Utilisation d'inhibiteurs de la mtap pour le traitement de maladies pulmonaires
US20060257432A1 (en) Pharmaceutical formulations of xanthogenates and inhibitors of viral nucelic acid replication
WO1994014457A1 (fr) Compositions efficaces contre des souches d'herpesvirus resistant a l'acyclovir
CA2514334A1 (fr) Nouvelles combinaisons de medicaments contre l'herpes
EP0723448A1 (fr) Utilisation de penciclorine dans le traitement des algies post-therapeutiques

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20040204

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

17Q First examination report despatched

Effective date: 20050503

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

RIC1 Information provided on ipc code assigned before grant

Ipc: 7A 61P 31/12 B

Ipc: 7A 61K 31/44 B

Ipc: 7A 61K 31/522 A

RTI1 Title (correction)

Free format text: PHARMACEUTICAL COMPOSITION COMPRISING ACYCLOVIR AND FUSARIC ACID

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20051205